IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.22 per share which beat the analyst consensus estimate of $3.13 by 2.84 percent. This is a 15.41 percent increase over earnings of $2.79 per share from the same period last year. The company reported quarterly sales of $1.105 billion which beat the analyst consensus estimate of $1.073 billion by 3.01 percent. This is a 13.27 percent increase over sales of $975.543 million the same period last year.